يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Eleanor Avril"', وقت الاستعلام: 0.85s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)

    المؤلفون: Petr Makhov, Igor Bychkov, Bulat Faezov, Alexander Deneka, Alexander Kudinov, Emmanuelle Nicolas, Rohan Brebion, Eleanor Avril, Kathy Q. Cai, Leonid V. Kharin, Mark Voloshin, Elena Frantsiyants, Nikolay Karnaukhov, Oleg I. Kit, Iuliia Topchu, Rushaniya Fazliyeva, Anna S. Nikonova, Ilya G. Serebriiskii, Hossein Borghaei, Martin Edelman, Essel Dulaimi, Erica A. Golemis, Yanis Boumber

    المصدر: Oncogenesis, Vol 10, Iss 3, Pp 1-14 (2021)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2157-9024Test

    الوصول الحر: https://doaj.org/article/2ede848ef5274440b27190aa152d7cbeTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)

    المؤلفون: Martin J. Edelman, Oleg I. Kit, Elena M. Frantsiyants, Rohan Brebion, Eleanor Avril, Kathy Q. Cai, Bulat Faezov, Iuliia Topchu, Rushaniya Fazliyeva, Ilya G. Serebriiskii, Emmanuelle Nicolas, Leonid V. Kharin, Petr Makhov, Yanis Boumber, Erica A. Golemis, Alexander E. Kudinov, Hossein Borghaei, Igor Bychkov, Alexander Y. Deneka, Anna S. Nikonova, Nikolay S. Karnaukhov, Essel Dulaimi, Mark Voloshin

    المصدر: Oncogenesis, Vol 10, Iss 3, Pp 1-14 (2021)
    Oncogenesis

    مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Afatinib, non-small cell lung cancer (NSCLC), lcsh:RC254-282, Article, 03 medical and health sciences, 0302 clinical medicine, medicine, Osimertinib, Epidermal growth factor receptor, Molecular Biology, EGFR inhibitors, biology, Cell growth, Chemistry, Reverse phase protein lysate microarray, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, respiratory tract diseases, 030104 developmental biology, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Erlotinib, Non-small-cell lung cancer, medicine.drug, Post-translational modifications

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e3f337bb99129d6a76a8fd9939b769aTest
    https://doaj.org/article/2ede848ef5274440b27190aa152d7cbeTest


    أضف إلى المفضلة
  3. 3
    Abstract 4452: Musashi-2 regulates EGFR/HER3 expression in NSCLC, cell proliferation and response to EGFR inhibitors in EGFR-mutant NSCLC

    المؤلفون: Hossein Borghaei, Kathy Q. Cai, Vladimir Khazak, Mark A. Hitrik, Peter Makhov, Anna S. Nikonova, Rohan Brebion, Ilya G. Serebriiskii, Yanis Boumber, Brian L. Egleston, Eleanor Avril, Erica A. Golemis, Emmanuelle Nicolas, Alexander E. Kudinov, Alexander Y. Deneka

    المصدر: Cancer Research. 78:4452-4452

    مصطلحات موضوعية: Cancer Research, Afatinib, Cancer, Biology, medicine.disease, medicine.disease_cause, Oncology, medicine, Cancer research, biology.protein, ERBB3, Erlotinib, Epidermal growth factor receptor, KRAS, Lung cancer, medicine.drug, EGFR inhibitors

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9fdae42960b49bd58967c4bd97f279e7Test
    https://doi.org/10.1158/1538-7445.am2018-4452Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث